A new research report titled; ‘Global Single use Bioprocessing Market’ has been added into the vast repository of research reports by MarketsandMarkets™ INC. The research report covers a detailed analysis of the overview of the market, overall size, share, product definition, supply chain analysis, supply chain ratio, upstream raw materials and equipment, downstream demand analysis, and import/export details. The report further analyses the different approaches, procedures, strategies, and methodologies adopted by the leading competitors operating in the market to make strategic key business decisions. Apart from the above-mentioned key findings, the report also states the growth rate of the global market, as well as the facts, figures, consumption tables, and statistics of the leading segments. Additionally, the Global Single use Bioprocessing Market research report provides an in-depth study of the current scenario of the market, along with the current and future industry trends, in order to identify the investment analysis.
The global single use bioprocessing market is expected to reach USD 20.8 billion by 2026 from USD 8.2 billion in 2021, at a CAGR of 20.5%
Furthermore, the Global Single use Bioprocessing Market Research Report provides the competitive landscape of the market and gathers information with regards to the company overview, contact information, market size and share, company’s headquarters and corporate offices, and sales revenue. The report also discusses the different development plans and policies of the industry, product pictures, and the process of manufacturing the product, production volume, and product draft. Moreover, the report provides an in-depth survey of the industry feasibleness, market strategies, investment return analysis, product volume, supply and demand ratio, market utilization value, and the industry chain value. In the last section of the report, the key distributors, suppliers, distinct traders, as well as the sales and distribution challenge, research findings, data resources, and appendix, have been studied.
Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=231651297
Single use Bioprocessing Industry | Key Market Players:
Sartorius Stedim Biotech S.A. (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Merck KGaA (Germany), Getinge AB (Sweden), Eppendorf AG (Germany), Corning (US), Entegris (US), Avantor (US), CESCO Bioengineering Co. Ltd. (Taiwan), Cellexus (UK), PBS Biotech, Inc. , Distek, Inc. (US), ABEC, Inc. (US), Able Corporation & Biott Corporation (Japan), G&G Technologies (US), Solida Biotech GmbH (Germany), Satake Chemical Equipment Mfg., Ltd. (Japan), Stobbe Pharma GmbH (Switzerland), Celltainer Biotech (Netherlands), Meissner Filtration Products, Inc. (US), bbi-biotech GmbH (Germany), Pierre Guerin (France), Kuhner AG (Switzerland), OmniBRx Biotechnologies (India).
Sartorius Stedim Biotech held the leading position in the single-use bioprocessing market in 2020. Sartorius focuses on strengthening its position in the market by adopting organic and inorganic strategies such as product launches and expansions. During the past three years, Sartorius Stedim Biotech launched SUB systems such as BIOSTAT STR Generation 3 Single-Use Bioreactor, BIOSTAT RM TX Single-Use Bioreactor, and BIOSTAT STR. In 2019, Sartorius acquired Danaher’s Life Science portfolio, which is complementary to the portfolio of Sartorius’s laboratory and bioprocess business. In 2019, the company also expanded their operations in Puerto Rico.
Thermo Fisher Scientific is the second-largest player in the single-use bioprocessing market. Thermo Fisher Scientific operates in the single-use bioprocessing market through the life science solutions business segment. To further increase its share in the single-use bioprocessing market, the company focuses on growth strategies such as acquisitions and expansion. From 2019 to 2021, the company expanded its business in the US. The company also made investments worth ~USD 650 million from 2019 to 2021 to enhance their single-use bioprocessing capabilities and increase their market share.
COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has since moved from being a regional crisis to a global pandemic. With the World Health Organization (WHO) officially declared the virus outbreak as a pandemic, a mix of established pharmaceutical companies and small startups had stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus.
Many biopharmaceutical companies have been rapidly developing vaccines in response to the novel coronavirus pandemic. If these development programs pass the trial phases, the clinical and commercial manufacturing platforms will be largely supported by single-use equipment and systems. Since most of the leading COVID-19 vaccine programs use novel approaches, including mRNA, DNA vaccine, and vectors, these platforms are largely built on single-use systems. Single-use systems are flexible and can quickly be put in place at a lower cost than traditional stainless-steel equipment, which has significant investments and no guarantee of longevity for the future.
Global Single use Bioprocessing Market Dynamics:
- DRIVER: The growing demand for biopharmaceuticals
- RESTRAINT: Issues related to leachables and extractables
- OPPORTUNITY: Emerging markets
- CHALLENGE: Waste disposal
This report categorizes the single use bioprocessing market into the following segments and subsegments:
- Single-use media bags and containers
- Single-use assemblies
- Single-use bioreactors
- Disposable mixers
- Other products
- Cell culture
- Biopharmaceutical & Pharmaceutical companies
- Contract Research Organizations and contract manufacturing organizations (CROs & CMOs)
- Academic & Research institutes
Some of the key geographies mentioned in this report include:
- North America (U.S and Canada and rest of North America)
- Europe (Germany, France, Italy, and Rest of Europe)
- Asia Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific)
- LAMEA (Brazil, Turkey, Saudi Arabia, South Africa, and Rest of LAMEA)
The research document will answer following questions such as:
- What is the size and share of the global market?
- What are the driving factors of the Global Single use Bioprocessing Market?
- What are the major next-generation techniques/developments stated in the market research report? What are the potential market opportunities of the Global Single use Bioprocessing Market?
- At what stage of development is the Global Single use Bioprocessing Market?
- What are the challenges and threats that the market is facing? Will the market be able to overcome these shortcomings and become commercially viable in the future?
- What are the growth prospects among the emerging nations throughout the forecast period?
- Who are the leading competitors functioning in the global market?
- What are the strengths and weaknesses of these leading players?
- What are the market opportunities and recommendations for new investors?
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road, Suite 430, Northbrook, IL 60062
USA: 1-888-600-6441 | email@example.com
Home Healthcare Market: https://www.marketsandmarkets.com/Market-Reports/home-healthcare-equipment-market-696.html
Optometry Equipment Market: https://www.marketsandmarkets.com/Market-Reports/optometry-eye-exam-equipment-market-14475790.html
Medical Electrodes Market: https://www.marketsandmarkets.com/Market-Reports/medical-electrode-market-171260948.html
Enteral Feeding Devices Market: https://www.marketsandmarkets.com/Market-Reports/enteral-feeding-device-market-183623035.html
Enteral feeding devices are important medical tools used to deliver medication and nutrients to prevent and manage various diseases. Growth in this market is largely driven by the shift from parenteral to enteral nutrition, the increasing incidence of preterm births, the growing demand for enteral feeding in the home care sector, and the increasing prevalence of chronic diseases.
Fresenius Kabi (Germany), Nestlé S.A. (Switzerland), Avanos Medical, Inc. (US), B. Braun Melsungen AG (Germany ), and Cardinal Health Inc. (US) are the leading players in the Enteral Feeding Devices Market.